Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JTT-302 in Subjects With Low HDL-C Levels
NCT00749788Phase 2Completed
- Sponsor
- Akros Pharma Inc.
- Start
- Dec 2006
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JTT-302 in dyslipidemia, sponsored by Akros Pharma Inc.. Started Dec 2006; status: completed.
02
Drugs
JTT-302
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00749788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00749788.